2015 ESC/ERS PH guidelines
PHA Europe
World Symposium on Pulmonary Hypertension (WSPH)
Opsumit®
A synopsis of the key benefits of OPSUMIT® in the treatment of PAH.
Details of the SERAPHIN study, where the safety and efficacy of OPSUMIT® were investigated in a Phase 3 study to assess the long-term benefits for pulmonary arterial hypertension (PAH) patients.